Legionella indianapolisensis sp. nov., isolated from a patient with pulmonary abscess by Relich, R. F. et al.
International Journal of Infectious Diseases 69 (2018) 26–28Case Report
Legionella indianapolisensis sp. nov., isolated from a patient with
pulmonary abscess
R.F. Relicha,*, B.H. Schmitta, H. Raposob, L. Barkerb, S.J. Blosserc, M. Mayb
aDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
bUniversity of New England, Biddeford, Maine, USA
c Indiana State Department of Health Laboratory, Indianapolis, Indiana, USA
A R T I C L E I N F O
Article history:
Received 2 December 2017
Received in revised form 17 January 2018
Accepted 19 January 2018










A B S T R A C T
Background: To date, at least 50 species of Legionella have been described. These organisms are ubiquitous
in nature and have been isolated from diverse ecological environments, including man-made structures
such as cooling towers and spas. Legionellae have also been isolated from human and veterinary clinical
specimens, and their roles in disease are well-established. This report describes the isolation of a novel
Legionella species from a respiratory specimen from a patient with inﬂuenza and suspected pulmonary
embolus.
Case: A 68-year-old male presented to an Indianapolis-area hospital with pulmonary disease; upon
workup, he was found to have inﬂuenza A. Bronchoalveolar lavage ﬂuid was also submitted for
conventional bacterial culture and Legionella culture. The patient was prescribed a broad-spectrum
antibiotic and recovered.
Results: A Legionella-like bacterium was isolated on buffered charcoal yeast extract agar, and mass
spectrometry and comparative 16S rRNA gene sequencing inconclusively identiﬁed the isolate as a
Legionella sp. Further analysis of the 16S rRNA gene conﬁrmed the strain to be a new species, related to
Legionella hackeliae. Physiochemical and morphological testing were used to conﬁrm the discovery of a
novel species, Legionella indianapolisensis sp. nov., type strain SMNF-IS.
© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Legionellae are rod-shaped, asaccharolytic, fastidious, faculta-
tively intracellular, and obligately aerobic Gram-negative bacteria
that are most often found growing in warm water environments,
including hot tubs, cooling towers, and water heaters, among other
places (Edelstein and Lück, 2015). Infections with these organisms
are referred to as legionellosis, an uncommon form of atypical
pneumonia. Legionellosis caused by Legionella pneumophila, the
primary causative agent of Legionnaire's disease, is perhaps best
known; however, other species, including Legionella bozemanae,
Legionella dumofﬁi, Legionella longbeachae, and Tatlockia micdadei
(formerly Legionella micdadei), also cause human infections (Cunha
and Cunha, 2017). Transmission to humans occurs through the
inhalation of organism-laden aerosols (Edelstein and Roy, 2014).* Corresponding author at: Division of Clinical Microbiology, Suite 6027, Indiana
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Subsequently, and generally following a 2- to 14-day incubation
period, disease symptoms develop and include cough, shortness of
breath, fever, and body aches (Edelstein and Lück, 2015).
Individuals with compromised respiratory systems and those
with underlying immunosuppression are at the highest risk of
infection and development of severe disease. Every year, between
8000 and 18 000 people are affected by Legionnaires’ disease in the
USA, of which approximately 10% die. Those who most often suffer
severe and fatal infections include smokers, the immunocompro-
mised, and individuals older than 50 years of age (Burillo et al.,
2017). Early detection and rapid initiation of antimicrobial therapy
is essential to prevent severe morbidity and mortality.
2. Case
The organism was isolated from a 68-year-old male patient who
presented to an Indianapolis-area hospital with an inﬂuenza-like
illness. The patient had a past medical history signiﬁcant for
thrombocytopenia and multiple myeloma. A chest X-ray was
performed and revealed left lower lobe inﬁltrates, and a computed
tomography scan showed a right-sided ﬁlling defect of the heart.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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cause of the patient's illness. During hospitalization, he was
diagnosed with a pulmonary embolus, left lung abscess, and a left
lower lobe pneumonia. A nucleic acid ampliﬁcation test for
inﬂuenza A was positive, prompting oseltamivir treatment. Gram
staining of the BAL ﬂuid did not reveal microorganisms; modiﬁed
acid-fast (MAF) and other stains were not performed. Four days
after the patient was discharged, an unidentiﬁed organism grew in
culture. Matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS), performed using a Bruker
MALDI Biotyper (Bruker Daltonics, Billerica, MA, USA), tentatively
identiﬁed the isolate as ‘Legionella species’. The patient was treated
with a 14-day course of levoﬂoxacin (750 mg/24 h) and recovered
fully.
3. Results and discussion
The organism isolated from the patient's BAL ﬂuid was cultured
on buffered charcoal yeast extract (BCYE) agar according to
standard methods. Gram staining of a representative colony
revealed faint-staining Gram-negative rods, and MAF staining
indicated that the organism was non-acid-fast. The isolate grew on
BCYE agar, but not on standard sheep blood agar, chocolate agar, or
other routine bacteriological culture media, suggesting that the
organism belonged to the genus Legionella. The isolate was non-
motile, oxidase-positive (weakly), and spot indole-negative.
Physiochemical testing of the isolate was attempted using the
VITEK 2 system (bioMérieux Inc., Durham, NC, USA); however, the
isolate failed to grow in the test card. The isolate did not hydrolyze
hippurate or produce catalase and demonstrated an absolute
requirement for L-cysteine; the latter phenotype was demonstrat-
ed by growth of the isolate on BCYE agar containing 2.5 mM L-
cysteine and lack of growth of the isolate on BCYE agar devoid of L-
cysteine. The isolate was also positive for b-lactamase activity. A
genus-level polyvalent direct ﬂuorescent antibody (DFA) test was
positive, but an L. pneumophila-speciﬁc DFA test was negative.
Taken together, these results supported the MALDI-TOF MS-
generated identiﬁcation of Legionella species.
Genomic DNA was isolated using a NucliSENS easyMAG
instrument (bioMérieux Inc.). The 16S ribosomal RNA gene was
ampliﬁed using the forward primer 27f (50-AGAGTTTGATCCT-30)Figure 1. Phylogeny and morphology of Legionella indianapolisensis. (A) Phylogenetic ana
(arrow) within the genus Legionella. Coxiella burnetii served as the outgroup. (B) Gramand the reverse primer 1492r (50-ACGGCTACCTTGT-30), as de-
scribed previously (Weisburg et al., 1991). Three distinct 1.5-kb
amplicons were sequenced using standard dideoxy methods (i.e.,
Sanger sequencing chemistry) by GenScript (Piscataway, NJ, USA).
The sequence similarities of the 16S rDNA between the isolate and
other Legionella species available in GenBank ranged from 94.9%
(1362/1435) to 96.7% (1389/1486), with Legionella hackeliae being
the most closely related species (multiple sequence alignment
viewable at doi 10.13140/RG.2.2.19151.79526; input sequence ﬁles
available at doi 10.13140/RG.2.2.34251.28966). Type species were
used whenever possible. Phylogenetic analysis was performed via
neighbor-joining method using MEGA 7.0 (Figure 1A).
Ribosomal RNA and phylogenetic analyses featuring 15 species
in the genus Legionella indicated that this isolate represented a
novel species, and was appropriately assigned to the genus
Legionella. Growth on BCYE agar but not sheep blood agar,
exogenous L-cysteine requirement, lack of catalase, sodium
hippurate hydrolysis, and genus-level DFA testing results further
support this assignment. The ribosomal RNA gene sequence and
mass spectral proﬁle are unique to this organism, as is the lack of
motility. Based on these data, we propose the formal name
Legionella indianapolisensis, sp. nov., strain SMNF-IS, after the
geographic location of its isolation.
3.1. Description of L. indianapolisensis sp. nov., strain SMNF-IS
L. indianapolisensis sp. nov. (in di an ap’ o li sen’ sis) N.L. neut. Of
Indianapolis, the geographic site of the index case. Cells are Gram-
negative, rod-shaped, and non-acid-fast (Figure 1B). Colonies are
white with a ground-glass appearance. Non-motile. Aerobic. Non-
sporulating. Chemoorganotroph. Sodium hippurate is hydrolyzed.
Oxidase is weakly produced. Unique 16S rRNA gene sequence
(GenBank accession number KT361191) distinct from the most
closely related species in the genus Legionella. First isolated from
the bronchoalveolar lavage ﬂuid from a man with pulmonary
abscess and concurrent inﬂuenza A in Indianapolis, Indiana, USA.
The type strain is SMNF-IS.
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